trial

Enhancing Cognitive Reserve of the Offsprings of Bipolar and Schizophrenic Patients

NCTId NCT03722082
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Unknown
Enrollment 173 (estimated)
Sponsored by Hospital Clinic of Barcelona
Primary completion 2022-02-01
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Unknown
Enrollment
173 (estimated)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Single
Start
2018-10-01
Primary completion
2022-02-01
Eligibility
ALL · 6 Years · 25 Years

Interventions & indications

Drugs
Enhancing cognitive reserveSupport intervention

Sponsors

Hospital Clinic of BarcelonaLead Sponsor
Institut d'Investigacions Biomèdiques August Pi i SunyerCollaborator
Consorcio Centro de Investigación Biomédica en Red (CIBER)Collaborator
Instituto de Salud Carlos IIICollaborator

Sites

1 total
Barcelona, Spain

Facts & assertions

4 sourced
Enrollment
173
Phase
NA
Primary Completion Date
2022-02-01
Status
UNKNOWN
relationships
The graph out of here
drug
Enhancing cognitive reserve
drug
Support intervention
drug
lead_sponsor
Hospital Clinic of Barcelona
company
collaborator
Institut d'Investigacions Biomèdiques August Pi i Sunyer
company
Consorcio Centro de Investigación Biomédica en Red (CIBER)
company
indication
Bipolar Disorder
indication
Schizophrenia
indication
Bipolar and Related Disorders
indication